S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › 0NCY › Research report
← 0NCY page
XStocksXray
Market X-Ray report · 20 October 2026

Lamda Development S.A. (0NCY)

London Exchange · UK · prices in GBP · close of 20 Oct 2026

Key indicators

Last closeGBP 5.700
52-week range5.700 – 7.189
Return, 1 month / 3 months+0.0% / +0.0%
Return, 1 year / 3 years+0.0% / +0.0%
TrendBelow its 200-day average
RSI (14)100
Volatility (1 year)0.0%
Worst drawdown (1 year)0.0%
Average daily value traded0.00M GBP
Dividend yield–

Market X-Ray price-based

60/ 100 · High confidence · ahead of 64% of stocks on this exchange
Trend64
Momentum48
Stability (higher is calmer)99
Liquidity6
Income–

Five-year price chart navy: price · brown: 200-day average

4.705.205.706.206.702021-102023-012024-042025-072026-10

About the company

Lamda Development is a Greek real estate development company based in Athens. It develops and manages property projects, including shopping centres, office buildings, residential complexes and marinas, and it is behind the redevelopment of the former Athens airport site into a coastal urban district. Its customers include retailers, businesses, residents and visitors who use its commercial and leisure properties across Greece.

On this site Lamda Development S.A. appears as a stock on the London Exchange (UK), code 0NCY, with prices in pounds sterling (GBP). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Lamda Development S.A. (0NCY) trades on the London Exchange in UK. It last closed at GBP 5.700 on 20 October 2026.

Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 1,371 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 0.0% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Lamda Development S.A. (0NCY)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend64 · FairMixed trend against its averages.
Above 200-day average0.0%
From 52-week high0.0%
Momentum48 · WeakLagging most stocks on this exchange.
3-month return0.0%
6-month return0.0%
12-month return, skipping the last month0.0%
Stability (higher is calmer)99 · StrongCalmer than most: low volatility and shallow drawdowns.
Volatility, 1 year (lower is calmer)0.0%
Worst drawdown, 1 year (smaller is calmer)0.0%
Liquidity6 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.00M GBP
Zero-volume days93.3%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.

Weak spots

  • Momentum: Lagging most stocks on this exchange.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+0.0%
1 month+0.0%
3 months+0.0%
6 months+0.0%
1 year+0.0%
3 years+0.0%
5 years+0.0%

Signals

50-day / 200-day average5.700 / 5.700
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.267

Technical summary

DailyBearish5 bullish · 2 neutral · 9 bearish
WeeklyBearish3 bullish · 2 neutral · 7 bearish
MonthlyBearish2 bullish · 2 neutral · 4 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026